Black Diamond Therapeutics (BDTX) Institutional Ownership $3.65 +0.05 (+1.28%) As of 02:46 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Black Diamond Therapeutics (NASDAQ:BDTX)CurrentInstitutional OwnershipPercentage95.47%Number ofInstitutional Buyers(last 12 months)59TotalInstitutional Inflows(last 12 months)$21.36MNumber ofInstitutional Sellers(last 12 months)19TotalInstitutional Outflows(last 12 months)$38.34M Get BDTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Black Diamond Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data BDTX Institutional Buying and Selling by Quarter Black Diamond Therapeutics Major Shareholders & Ownership History ExportReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/19/2026 Bank of America Corp DE114,143$243K0.0%+123.4%0.199% 5/18/2026 Empowered Funds LLC230,177$490K0.0%N/A0.402% 5/15/2026 OMERS ADMINISTRATION Corp62,800$134K0.0%-54.8%0.110% 5/14/2026 Renaissance Technologies LLC1,643,747$3.50M0.0%+73.1%2.869% 5/14/2026 Arrowstreet Capital Limited Partnership834,570$1.78M0.0%-19.8%1.456% 5/14/2026 Sei Investments Co.39,683$85K0.0%N/A0.069% 5/7/2026 Dimensional Fund Advisors LP1,301,664$2.77M0.0%+51.9%2.272% 5/5/2026 Bank of New York Mellon Corp189,148$403K0.0%-11.9%0.330% 4/28/2026 Kathmere Capital Management LLC13,813$29K0.0%-56.6%0.024% 4/20/2026 Ritholtz Wealth Management165,333$352K0.0%-27.4%0.289% Get the Latest News and Ratings for BDTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Black Diamond Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 4/17/2026 Brookstone Capital Management14,290$30K0.0%N/A0.025% 2/19/2026 T. Rowe Price Investment Management Inc.10,606,599$25.78M0.0%-1.3%18.618% 2/19/2026 Invesco Ltd.131,438$319K0.0%+37.9%0.231% 2/18/2026 Mackenzie Financial Corp352,454$876K0.0%N/A0.619% 2/18/2026 XTX Topco Ltd119,679$291K0.0%-44.6%0.210% 2/18/2026 nVerses Capital LLC10,722$26K0.1%N/A0.019% 2/18/2026 Stokes Family Office LLC11,077$27K0.0%N/A0.019% 2/18/2026 Verdad Advisers LP96,286$234K0.1%N/A0.169% 2/18/2026 Vestal Point Capital LP870,000$2.11M0.1%-84.3%1.527% 2/18/2026 Susquehanna Portfolio Strategies LLC158,984$386K0.0%-24.7%0.279% 2/18/2026 Oxford Asset Management LLP114,383$278K0.1%N/A0.201% 2/18/2026 Millennium Management LLC296,556$721K0.0%-65.1%0.521% 2/18/2026 Man Group plc130,033$316K0.0%+66.0%0.228% 2/18/2026 Engineers Gate Manager LP19,701$48K0.0%+48.9%0.035% 2/18/2026 Bridgeway Capital Management LLC173,300$421K0.0%+76.3%0.304% 2/18/2026 683 Capital Management LLC247,958$603K0.0%N/A0.435% 2/17/2026 J. Goldman & Co LP270,000$656K0.0%N/A0.474% 2/17/2026 Jump Financial LLC39,026$95K0.0%N/A0.069% 2/17/2026 T. Rowe Price Investment Management Inc.2,332,222$5.67M0.0%-78.3%4.094% 2/17/2026 Graham Capital Management L.P.86,556$210K0.0%+137.0%0.152% 2/16/2026 OMERS ADMINISTRATION Corp138,900$338K0.0%+1,162.7%0.244% 2/16/2026 Barclays PLC74,810$182K0.0%+227.1%0.131% 2/13/2026 Marshall Wace LLP1,110,088$2.70M0.0%-14.6%1.949% 2/13/2026 Stifel Financial Corp274,995$668K0.0%+23.7%0.483% 2/13/2026 AWM Investment Company Inc.625,000$1.52M0.1%+4.2%1.097% 2/12/2026 HRT Financial LP26,351$64K0.0%N/A0.046% 2/12/2026 Renaissance Technologies LLC949,735$2.31M0.0%+58.4%1.667% 2/12/2026 Dimensional Fund Advisors LP857,015$2.08M0.0%+88.0%1.504% 2/12/2026 AlphaCentric Advisors LLC53,625$130K0.1%N/A0.094% 2/11/2026 LPL Financial LLC36,990$90K0.0%-46.6%0.065% Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (Ad)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.Get the name and ticker of Louis Navellier's #1 AI stock free2/11/2026 O Shaughnessy Asset Management LLC354,454$861K0.0%+148.8%0.622% 2/11/2026 WINTON GROUP Ltd421,280$1.02M0.0%N/A0.739% 2/11/2026 State of Wyoming70,343$171K0.0%+189.6%0.123% 2/10/2026 TD Asset Management Inc195,930$476K0.0%+6.8%0.344% 2/10/2026 Goldman Sachs Group Inc.325,327$791K0.0%-27.5%0.571% 2/9/2026 Geode Capital Management LLC505,780$1.23M0.0%+1.1%0.888% 2/3/2026 RB Capital Management LLC35,000$85K0.0%N/A0.061% 1/27/2026 Round Rock Advisors LLC79,539$193K0.0%N/A0.140% 1/27/2026 HCR Wealth Advisors27,000$66K0.0%N/A0.047% 1/23/2026 Ritholtz Wealth Management227,870$554K0.0%+124.5%0.400% 1/13/2026 Kathmere Capital Management LLC31,822$77K0.0%+31.0%0.056% 11/17/2025 XTX Topco Ltd216,195$819K0.0%+20.6%0.379% 11/17/2025 Vestal Point Capital LP5,550,000$21.03M0.9%-0.9%9.742% 11/17/2025 Qube Research & Technologies Ltd78,266$297K0.0%+17.8%0.137% 11/17/2025 Millennium Management LLC850,331$3.22M0.0%-10.0%1.493% 11/17/2025 Bank of America Corp DE43,359$164K0.0%+22.5%0.076% 11/14/2025 Raymond James Financial Inc.17,215$65K0.0%-53.3%0.030% 11/14/2025 Virtu Financial LLC10,415$39K0.0%N/A0.018% 11/14/2025 Man Group plc78,326$297K0.0%+88.4%0.137% 11/14/2025 Squarepoint Ops LLC17,181$65K0.0%-79.4%0.030% 11/13/2025 Kennedy Capital Management LLC129,944$492K0.0%+97.3%0.228% 11/13/2025 Arrowstreet Capital Limited Partnership896,853$3.40M0.0%+549.2%1.574% 11/13/2025 UBS Group AG628,416$2.38M0.0%+100.3%1.103% 11/13/2025Jefferies Financial Group Inc.22,800$86K0.0%N/A0.040% 11/10/2025 TD Asset Management Inc183,420$695K0.0%+10.7%0.322% 11/10/2025 Hillsdale Investment Management Inc.63,623$241K0.0%N/A0.112% 11/7/2025 GSA Capital Partners LLP122,758$465K0.0%-48.9%0.216% 11/7/2025Vanguard Group Inc.2,188,857$8.30M0.0%+4.1%3.844% 11/4/2025 Brown Wealth Management LLC20,932$79K0.0%-79.1%0.037% 11/4/2025 State of Wyoming24,292$92K0.0%N/A0.043% 10/28/2025 Ritholtz Wealth Management101,479$385K0.0%N/A0.178% 10/22/2025 Kathmere Capital Management LLC24,283$92K0.0%N/A0.043% 10/17/2025 Ethic Inc.15,592$59K0.0%N/A0.027% 8/18/2025 Hudson Bay Capital Management LP10,440$26K0.0%N/A0.018% 8/15/2025 Tower Research Capital LLC TRC 21,031$52K0.0%+217.6%0.037% 8/15/2025 Man Group plc41,577$103K0.0%N/A0.073% 8/15/2025 Hudson Bay Capital Management LP10,440$26K0.0%N/A0.018% 8/15/2025 Engineers Gate Manager LP32,884$82K0.0%N/A0.058% 8/15/2025 Bridgeway Capital Management LLC98,300$244K0.0%+34.5%0.173% 8/15/2025 Bank of America Corp DE35,387$88K0.0%-23.2%0.062% 8/14/2025 Jane Street Group LLC208,477$517K0.0%N/A0.366% 8/14/2025 Qube Research & Technologies Ltd66,451$165K0.0%+158.1%0.117% 8/14/2025 Cerity Partners LLC10,299$26K0.0%N/A0.018% 8/13/2025 Jump Financial LLC13,065$32K0.0%N/A0.023% 8/13/2025 Marshall Wace LLP737,875$1.83M0.0%N/A1.296% 8/13/2025 Invesco Ltd.60,210$149K0.0%+30.9%0.106% 8/13/2025 Arrowstreet Capital Limited Partnership138,144$343K0.0%N/A0.243% 8/12/2025 XTX Topco Ltd179,234$444K0.0%+324.7%0.315% 8/12/2025 Prudential Financial Inc.13,100$32K0.0%N/A0.023% 8/12/2025 American Century Companies Inc.12,144$30K0.0%N/A0.021% $30 stock to buy before Starlink goes public (WATCH NOW!) (Ad)A little-known stock pick with money-doubling potential over the next year is revealed for free in the first three minutes of a new video. This company is a critical piece of Elon Musk's fast-growing Starlink technology. It could climb 100 percent or more over the next year as Elon brings Starlink public in what may be the biggest IPO in history. No credit card is required to get the ticker.Watch the free video to get the ticker today.8/12/2025 Catalyst Funds Management Pty Ltd18,500$46K0.0%N/A0.032% 8/8/2025 Bailard Inc.15,800$39K0.0%N/A0.028% 8/8/2025 Geode Capital Management LLC495,343$1.23M0.0%-48.7%0.871% 8/1/2025 Y Intercept Hong Kong Ltd14,521$36K0.0%N/A0.026% 7/31/2025 R Squared Ltd10,139$25K0.0%N/A0.018% 7/25/2025 CWM LLC14,338$36K0.0%+212.2%0.025% 7/10/2025 Wealth Enhancement Advisory Services LLC10,984$28K0.0%N/A0.019% 7/9/2025 DLK Investment Management LLC20,200$50K0.0%+26.3%0.036% 6/27/2025 Goldman Sachs Group Inc.479,387$743K0.0%-0.9%0.843% 5/16/2025AQR Capital Management LLC54,122$84K0.0%N/A0.095% BDTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BDTX shares? During the previous two years, 104 institutional investors and hedge funds held shares of Black Diamond Therapeutics. The most heavily invested institutionals were T. Rowe Price Investment Management Inc. ($25.78M), Vanguard Group Inc. ($8.30M), Tang Capital Management LLC ($4.43M), Ally Bridge Group NY LLC ($3.89M), State Street Corp ($3.52M), Renaissance Technologies LLC ($3.50M), and Point72 Asset Management L.P. ($3.03M).Learn more on Black Diamond Therapeutics' institutional investors. What percentage of Black Diamond Therapeutics' stock is owned by institutional investors? 95.47% of Black Diamond Therapeutics' stock is owned by institutional investors. Learn more on BDTX's institutional investor holdings. Which institutional investors have been buying Black Diamond Therapeutics' stock? Of the 94 institutional investors that purchased Black Diamond Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Vestal Point Capital LP ($3.50M), Renaissance Technologies LLC ($1.75M), Dimensional Fund Advisors LP ($1.34M), Affinity Asset Advisors LLC ($1.21M), Arrowstreet Capital Limited Partnership ($896.85K), Ally Bridge Group NY LLC ($835K), and Marshall Wace LLP ($832.41K). How much institutional buying is happening at Black Diamond Therapeutics? Institutional investors have bought a total of 8,049,639 shares in the last 24 months. This purchase volume represents approximately $21.36M in transactions. Which of Black Diamond Therapeutics' major shareholders have been selling company stock? Of the 19 institutional investors that sold Black Diamond Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: T. Rowe Price Investment Management Inc. ($8.55M), Vestal Point Capital LP ($4.73M), Millennium Management LLC ($648.30K), Geode Capital Management LLC ($470.26K), Arrowstreet Capital Limited Partnership ($205.90K), Marshall Wace LLP ($189.12K), and Goldman Sachs Group Inc. ($128.14K). How much institutional selling is happening at Black Diamond Therapeutics? Institutional investors have sold a total of 15,577,099 shares in the last 24 months. This volume of shares sold represents approximately $38.34M in transactions. Related Companies CTMX Institutional Ownership STRO Institutional Ownership ZVRA Institutional Ownership ARVN Institutional Ownership CLYM Institutional Ownership TLRY Institutional Ownership CRMD Institutional Ownership CADL Institutional Ownership PRME Institutional Ownership AVTX Institutional Ownership This page (NASDAQ:BDTX) was last updated on 5/21/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Black Diamond Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Black Diamond Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
